|
 |
|
|||||||
|
|||||||||
Reviews
Lipoprotein metabolism in diabetes mellitus
BV Howard
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Medicine..Lipoproteins
- Medicine..Lipases
- Medicine..Diabetes Mellitus
- Biochemistry..Low-Density Lipoproteins
- Physiology..Humans
- Biochemistry..Lipoprotein Metabolism
- Medicine..Non-Insulin-Dependent Diabetes Mellitus
- Biophysics..Metabolism
- Medicine..Cholesterol
- Medicine..Diabetes
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Qin, R. A. Anderson, and K. Adeli Tumor necrosis factor-{alpha} directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1120 - G1129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Albers, S. M. Marcovina, G. Imperatore, B. M. Snively, J. Stafford, W. Y. Fujimoto, E. J. Mayer-Davis, D. B. Petitti, C. Pihoker, L. Dolan, et al. Prevalence and Determinants of Elevated Apolipoprotein B and Dense Low-Density Lipoprotein in Youths with Type 1 and Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 735 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. N Bavenholm and S. Efendic Postprandial hyperglycaemia and vascular damage - the benefits of acarbose Diabetes and Vascular Disease Research, September 1, 2006; 3(2): 72 - 79. [Abstract] [PDF]
|
|
|
|
|
|
H. N. Ginsberg REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 383 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Woerle, E. Szoke, C. Meyer, J. M. Dostou, S. D. Wittlin, N. R. Gosmanov, S. L. Welle, and J. E. Gerich Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E67 - E77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Myerson, C. Ngai, J. Jones, S. Holleran, R. Ramakrishnan, L. Berglund, and H. N. Ginsberg Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia J. Lipid Res., December 1, 2005; 46(12): 2735 - 2744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Iwasaki, S. Takahashi, M. Takahashi, Y. Zenimaru, T. Kujiraoka, M. Ishihara, M. Nagano, J. Suzuki, I. Miyamori, H. Naiki, et al. Deficiency of the Very Low-Density Lipoprotein (VLDL) Receptors in Streptozotocin-Induced Diabetic Rats: Insulin Dependency of the VLDL Receptor Endocrinology, August 1, 2005; 146(8): 3286 - 3294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. W. Lau, M. Journoud, and P. J. Jones Plant sterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1351 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Brehm, G. Pfeiler, G. Pacini, H. Vierhapper, and M. Roden Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity Clin. Chem., December 1, 2004; 50(12): 2316 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Pruneta-Deloche, A. Sassolas, G. M. Dallinga-Thie, F. Berthezene, G. Ponsin, and P. Moulin Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes J. Lipid Res., May 1, 2004; 45(5): 859 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ouguerram, T. Magot, Y. Zair, J. S. Marchini, B. Charbonnel, H. Laouenan, and M. Krempf Effect of Atorvastatin on Apolipoprotein B100 Containing Lipoprotein Metabolism in Type-2 Diabetes J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 332 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Valabhji and R. S Elkeles Dyslipidaemia in type 2 diabetes: epidemiology and biochemistry The British Journal of Diabetes & Vascular Disease, May 1, 2003; 3(3): 184 - 189. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Duvillard, E. Florentin, G. Lizard, J.-M. Petit, F. Galland, S. Monier, P. Gambert, and B. Verges Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care, May 1, 2003; 26(5): 1540 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Lee, M. A. Magnuson, V. Muppala, and S.-S. Chen Liver-Specific Reactivation of the Inactivated Hnf-1{alpha} Gene: Elimination of Liver Dysfunction To Establish a Mouse MODY3 Model Mol. Cell. Biol., February 1, 2003; 23(3): 923 - 932. [Abstract] [Full Text]
|
|
|
|
|
|
A. Georgopoulos, O. Aras, M. Noutsou, and M. Y. Tsai Unlike Type 2 Diabetes, Type 1 Does Not Interact with the Codon 54 Polymorphism of the Fatty Acid Binding Protein 2 Gene J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3735 - 3739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Sniderman, T. Scantlebury, and K. Cianflone Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus Ann Intern Med, September 18, 2001; 135(6): 447 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Wajchenberg Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome Endocr. Rev., December 1, 2000; 21(6): 697 - 738. [Abstract] [Full Text]
|
|
|
|
|
|
R. Frikke-Schmidt, B. G. Nordestgaard, B. Agerholm-Larsen, P. Schnohr, and A. Tybjærg-Hansen Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype J. Lipid Res., November 1, 2000; 41(11): 1812 - 1822. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Georgopoulos, J. P. Bantle, M. Noutsou, and H. A. Hoover A High Carbohydrate versus a High Monounsaturated Fatty Acid Diet Lowers the Atherogenic Potential of Big VLDL Particles in Patients with Type 1 Diabetes J. Nutr., October 1, 2000; 130(10): 2503 - 2507. [Abstract] [Full Text]
|
|
|
|
|
|
P. Simonen, H. Gylling, A. N Howard, and T. A Miettinen Introducing a new component of the metabolic syndrome: low cholesterol absorption Am. J. Clinical Nutrition, July 1, 2000; 72(1): 82 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Taghibiglou, A. Carpentier, S. C. Van Iderstine, B. Chen, D. Rudy, A. Aiton, G. F. Lewis, and K. Adeli Mechanisms of Hepatic Very Low Density Lipoprotein Overproduction in Insulin Resistance. EVIDENCE FOR ENHANCED LIPOPROTEIN ASSEMBLY, REDUCED INTRACELLULAR ApoB DEGRADATION, AND INCREASED MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN IN A FRUCTOSE-FED HAMSTER MODEL J. Biol. Chem., March 17, 2000; 275(12): 8416 - 8425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Knobler, A. Schattner, T. Zhornicki, S.D.H. Malnick, D. Keter, N. Sokolovskaya, Y. Lurie, and D.D. Bass Fatty liver—an additional and treatable feature of the insulin resistance syndrome QJM, February 1, 1999; 92(2): 73 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M D FEHER and R S ELKELES Lipid modification and coronary heart disease in type 2 diabetes: different from the general population? Heart, January 1, 1999; 81(1): 10 - 11. [Full Text]
|
|
|
|
|
|
L. S. Sidossis, B. Mittendorfer, E. Walser, D. Chinkes, and R. R. Wolfe Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E798 - E805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aarsland and R. R. Wolfe Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men J. Lipid Res., June 1, 1998; 39(6): 1280 - 1286. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Georgopoulos, J. P. Bantle, M. Noutsou, W. R. Swaim, and S. J. Parker Differences in the Metabolism of Postprandial Lipoproteins After a High-Monounsaturated-Fat Versus a High-Carbohydrate Diet in Patients With Type 1 Diabetes Mellitus Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 773 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Fisher, L. A. Zech, and P. W. Stacpoole Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet J. Lipid Res., February 1, 1998; 39(2): 388 - 401. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Bressler and D. G. Johnson Pharmacological Regulation of Blood Glucose Levels in Non--Insulin-Department Diabetes Mellitus Arch Intern Med, April 28, 1997; 157(8): 836 - 848. [Abstract] [PDF]
|
|
|
|
|
|
P. J. Coussons, C. S. Bourgeois, D. Wiggins, and G. F. Gibbons Selective Recruitment of ApoB-48 for the Assembly of VLDL in Rat Triacylglycerol-Enriched Hepatocytes Arterioscler. Thromb. Vasc. Biol., July 1, 1996; 16(7): 889 - 897. [Abstract] [Full Text]
|
|
|
|
|
|
A. T.K. Singh, D. L. Rainwater, S. M. Haffner, J. L. VandeBerg, W. R. Shelledy, P. H. Moore Jr, and T. D. Dyer Effect of Diabetes on Lipoprotein Size Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1805 - 1811. [Abstract] [Full Text]
|
|
|
|
|
|
C. E. Tan, L. Forster, M. J. Caslake, D. Bedford, T. D. G. Watson, M. McConnell, C. J. Packard, and J. Shepherd Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1839 - 1848. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Delcker, H.C. Diener, and H. Wilhelm Influence of Vascular Risk Factors for Atherosclerotic Carotid Artery Plaque Progression Stroke, November 1, 1995; 26(11): 2016 - 2022. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Syvanne, J. Kahri, K. S. Virtanen, and M.-R. Taskinen HDLs Containing Apolipoproteins A-I and A-II (LpA-I:A-II) as Markers of Coronary Artery Disease in Men With Non–Insulin- Dependent Diabetes Mellitus Circulation, August 1, 1995; 92(3): 364 - 370. [Abstract] [Full Text]
|
|
|
|
|
|
G. E. Reiber, R. E. Pecoraro, and T. D. Koepsell Risk Factors for Amputation in Patients with Diabetes Mellitus: A Case-Control Study Ann Intern Med, July 15, 1992; 117(2): 97 - 105. [Abstract] [PDF]
|
|
|
|
|
|
L. C. Ramirez, C. Arauz-Pacheco, C. Lackner, G. Albright, B. V. Adams, and P. Raskin Lipoprotein (a) Levels in Diabetes Mellitus: Relationship to Metabolic Control Ann Intern Med, July 1, 1992; 117(1): 42 - 47. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Henkin, J. A. Como, and A. Oberman Secondary Dyslipidemia: Inadvertent Effects of Drugs in Clinical Practice JAMA, February 19, 1992; 267(7): 961 - 968. [Abstract] [PDF]
|
|
|
|
|
|
C. D. Saudek When Does Diabetes Start? JAMA, June 6, 1990; 263(21): 2934 - 2934. [Abstract] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||